Author Sklaviadis, Theodoros
-
2006 | Journal Article
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
Sanchez-Juan, P.; Green, A.; Ladogana, A.; Cuadrado-Corrales, N.; Sanchez-Valle, R.; Mitrova, E. & Stoeck, K. et al. (2006)
Neurology, 67(4) pp. 637-643. DOI: https://doi.org/10.1212/01.wnl.0000230159.67128.00
Details DOI PMID PMC WoS
-
2007 | Journal Article
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies
Green, A.; Sanchez-Juan, P.; Ladogana, A.; Cuadrado-Corrales, N.; Sanchez-Valle, R.; Mitrova, E. & Stoeck, K. et al. (2007)
European Journal of Neurology, 14(2) pp. 121-124. DOI: https://doi.org/10.1111/j.1468-1331.2006.01630.x
Details DOI PMID PMC WoS
-
2009 | Journal Article |
Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies
Ladogana, A.; Sanchez-Juan, P.; Mitrova, E.; Green, A.; Cuadrado-Corrales, N.; Sanchez-Valle, R. & Koscova, S. et al. (2009)
Journal of Neurology, 256(10) pp. 1620-1628. DOI: https://doi.org/10.1007/s00415-009-5163-x
Details DOI PMID PMC WoS
-
2017 | Journal Article |
YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
Llorens, F.; Thüne, K.; Tahir, W.; Kanata, E.; Diaz-Lucena, D.; Xanthopoulos, K. & Kovatsi, E. et al. (2017)
Molecular Neurodegeneration, 12(1) art. 83. DOI: https://doi.org/10.1186/s13024-017-0226-4
Details DOI
-
2017 | Journal Article
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
Llorens, F. ; Kruse, N. ; Schmitz, M. ; Gotzmann, N. ; Golanska, E.; Thüne, K. & Zejneli, O. et al. (2017)
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 13(6) pp. 710-719. DOI: https://doi.org/10.1016/j.jalz.2016.09.013
Details DOI PMID PMC
-
2018 | Journal Article |
Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis
Llorens, F. ; Thüne, K. ; Martí, E.; Kanata, E.; Dafou, D.; Díaz-Lucena, D. & Vivancos, A. et al. (2018)
PLOS Pathogens, 14(1) art. e1006802. DOI: https://doi.org/10.1371/journal.ppat.1006802
Details DOI
-
2018 | Journal Article |
MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives
Kanata, E.; Thüne, K.; Xanthopoulos, K.; Ferrer, I.; Dafou, D.; Zerr, I. & Sklaviadis, T. et al. (2018)
Frontiers in Aging Neuroscience, 10 art. 220. DOI: https://doi.org/10.3389/fnagi.2018.00220
Details DOI PMID PMC
-
2019 | Journal Article
Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency
Schmitz, M. ; Candelise, N. ; Kanata, E.; Llorens, F. ; Thüne, K. ; Villar-Piqué, A. & da Silva Correia, S. M. et al. (2019)
Molecular Neurobiology, 57(4) pp. 1863-1874. DOI: https://doi.org/10.1007/s12035-019-01837-w
Details DOI
-
2019 | Journal Article
RNA editing alterations define manifestation of prion diseases
Kanata, E.; Llorens, F.; Dafou, D.; Dimitriadis, A.; Thüne, K.; Xanthopoulos, K. & Bekas, N. et al. (2019)
Proceedings of the National Academy of Sciences, 116(39) pp. 19727-19735. DOI: https://doi.org/10.1073/pnas.1803521116
Details DOI
-
2022 | Journal Article | Research Paper |
Carnosic Acid and Carnosol Display Antioxidant and Anti-Prion Properties in In Vitro and Cell-Free Models of Prion Diseases
Karagianni, K.; Pettas, S.; Kanata, E.; Lioulia, E.; Thune, K.; Schmitz, M. & Tsamesidis, I. et al. (2022)
Antioxidants, 11(4) pp. 726. DOI: https://doi.org/10.3390/antiox11040726
Details DOI